FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2290232366> ?p ?o ?g. }

• W2290232366 endingPage "162" @default.
• W2290232366 startingPage "156" @default.
• W2290232366 abstract "Abstract Previous studies suggested a role for prostaglandins or thromboxane A2, or both in the exposure of fibrinogen receptors on normal platelets in response to several aggregating agents. Platelets from diabetics are known to be more sensitive to aggregating agents and to produce more prostaglandins and thromboxane than platelets from normal subjects. We compared fibrinogen binding to platelets from diabetic subjects with binding to platelets from normal subjects and determined whether aspirin (which inhibits the formation of prostaglandins and thromboxane) would inhibit the binding of fibrinogen to platelets from diabetic subjects and whether this correlated with its effects on platelet aggregation. We found the following: Aspirin suppressed thromboxane formation and rendered the platelets less sensitive to the induction of aggregation by adenosine diphosphate (ADP) or collagen. The amount of U-46619 [( 15s]-hydroxy-11-alpha, 9-alpha [epoxy-methano]- prosta[5Z,13E]-dienoic acid, a stable analog of prostaglandin endoperoxide/thromboxane A2) necessary to induce aggregation, was similar in normal and diabetic subjects and was unchanged after ingestion of aspirin. Binding of 125I-fibrinogen following stimulation of platelets by ADP or collagen was greater in diabetic (because more binding sites were exposed) than in normal subjects. However, following stimulation by U-46619, binding was similar in diabetic and normal subjects. Aspirin caused a reduction in the exposure of binding sites on both platelets from diabetic and normal subjects, so that (in this respect) platelets from diabetic subjects became more like those from normal subjects. Effects of the monoclonal antibody B59.2, which is specific for the platelet glycoprotein IIb-IIIa complex (the presumed receptor for fibrinogen on the platelet surface) were also studied. The amount of this antibody that bound to platelets was the same for normal and diabetic subjects both before and after aspirin and with or without stimulation by ADP or collagen. In addition, B59.2 inhibited aggregation and fibrinogen binding in both platelets from diabetic and normal subjects. The combined data suggest that the glycoprotein IIb- IIIa complex of platelets from diabetic subjects is similar to that of platelets from normal subjects and that the increased fibrinogen binding and aggregation of platelets from diabetic subjects in response to ADP or collagen is mediated by increased formation of prostaglandin endoperoxide or thromboxane A2, or both." @default.
• W2290232366 created "2016-06-24" @default.
• W2290232366 creator A5000642225 @default.
• W2290232366 creator A5034305652 @default.
• W2290232366 creator A5041306496 @default.
• W2290232366 creator A5043841427 @default.
• W2290232366 creator A5061059691 @default.
• W2290232366 creator A5067557852 @default.
• W2290232366 creator A5080166458 @default.
• W2290232366 date "1985-01-01" @default.
• W2290232366 modified "2023-10-01" @default.
• W2290232366 title "Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane" @default.
• W2290232366 cites W1210672469 @default.
• W2290232366 cites W149224131 @default.
• W2290232366 cites W1499223801 @default.
• W2290232366 cites W1546132586 @default.
• W2290232366 cites W1761018113 @default.
• W2290232366 cites W1986971270 @default.
• W2290232366 cites W1988422524 @default.
• W2290232366 cites W1992650719 @default.
• W2290232366 cites W1992792869 @default.
• W2290232366 cites W1994855991 @default.
• W2290232366 cites W1995491330 @default.
• W2290232366 cites W1998321319 @default.
• W2290232366 cites W2009554982 @default.
• W2290232366 cites W2009967151 @default.
• W2290232366 cites W2024559337 @default.
• W2290232366 cites W2035423234 @default.
• W2290232366 cites W2041704958 @default.
• W2290232366 cites W2049311704 @default.
• W2290232366 cites W2051322044 @default.
• W2290232366 cites W2057667692 @default.
• W2290232366 cites W2063835214 @default.
• W2290232366 cites W2077822807 @default.
• W2290232366 cites W2082921756 @default.
• W2290232366 cites W2090243052 @default.
• W2290232366 cites W2092714750 @default.
• W2290232366 cites W2100646356 @default.
• W2290232366 cites W2165051679 @default.
• W2290232366 cites W2170684533 @default.
• W2290232366 cites W2317586245 @default.
• W2290232366 cites W2330518106 @default.
• W2290232366 cites W2398122224 @default.
• W2290232366 cites W2399132423 @default.
• W2290232366 cites W2409604495 @default.
• W2290232366 cites W2411245105 @default.
• W2290232366 cites W2419137097 @default.
• W2290232366 cites W2420700608 @default.
• W2290232366 cites W2474728304 @default.
• W2290232366 cites W3998058 @default.
• W2290232366 cites W76482949 @default.
• W2290232366 cites W938490368 @default.
• W2290232366 cites W99141022 @default.
• W2290232366 cites W2394858131 @default.
• W2290232366 doi "https://doi.org/10.1182/blood.v65.1.156.156" @default.
• W2290232366 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2981130" @default.
• W2290232366 hasPublicationYear "1985" @default.
• W2290232366 type Work @default.
• W2290232366 sameAs 2290232366 @default.
• W2290232366 citedByCount "48" @default.
• W2290232366 countsByYear W22902323662013 @default.
• W2290232366 countsByYear W22902323662015 @default.
• W2290232366 countsByYear W22902323662016 @default.
• W2290232366 countsByYear W22902323662017 @default.
• W2290232366 crossrefType "journal-article" @default.
• W2290232366 hasAuthorship W2290232366A5000642225 @default.
• W2290232366 hasAuthorship W2290232366A5034305652 @default.
• W2290232366 hasAuthorship W2290232366A5041306496 @default.
• W2290232366 hasAuthorship W2290232366A5043841427 @default.
• W2290232366 hasAuthorship W2290232366A5061059691 @default.
• W2290232366 hasAuthorship W2290232366A5067557852 @default.
• W2290232366 hasAuthorship W2290232366A5080166458 @default.
• W2290232366 hasBestOaLocation W22902323661 @default.
• W2290232366 hasConcept C126322002 @default.
• W2290232366 hasConcept C134018914 @default.
• W2290232366 hasConcept C185592680 @default.
• W2290232366 hasConcept C24998067 @default.
• W2290232366 hasConcept C2776785769 @default.
• W2290232366 hasConcept C2777399203 @default.
• W2290232366 hasConcept C2777628954 @default.
• W2290232366 hasConcept C2779036427 @default.
• W2290232366 hasConcept C2781024287 @default.
• W2290232366 hasConcept C2781080829 @default.
• W2290232366 hasConcept C2909278008 @default.
• W2290232366 hasConcept C2993802102 @default.
• W2290232366 hasConcept C71924100 @default.
• W2290232366 hasConcept C89560881 @default.
• W2290232366 hasConceptScore W2290232366C126322002 @default.
• W2290232366 hasConceptScore W2290232366C134018914 @default.
• W2290232366 hasConceptScore W2290232366C185592680 @default.
• W2290232366 hasConceptScore W2290232366C24998067 @default.
• W2290232366 hasConceptScore W2290232366C2776785769 @default.
• W2290232366 hasConceptScore W2290232366C2777399203 @default.
• W2290232366 hasConceptScore W2290232366C2777628954 @default.
• W2290232366 hasConceptScore W2290232366C2779036427 @default.
• W2290232366 hasConceptScore W2290232366C2781024287 @default.
• W2290232366 hasConceptScore W2290232366C2781080829 @default.
• W2290232366 hasConceptScore W2290232366C2909278008 @default.

• next